BENJAMIN MUSHER to Pancreatic Neoplasms
This is a "connection" page, showing publications BENJAMIN MUSHER has written about Pancreatic Neoplasms.
Connection Strength
1.412
-
LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study. Lancet Oncol. 2024 Apr; 25(4):488-500.
Score: 0.594
-
Oncolytic viral therapy for pancreatic cancer. J Surg Oncol. 2017 Jul; 116(1):94-103.
Score: 0.366
-
Development of an artificial intelligence-derived histologic signature associated with adjuvant gemcitabine treatment outcomes in pancreatic cancer. Cell Rep Med. 2023 04 18; 4(4):101013.
Score: 0.139
-
A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects With Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer. Ann Surg. 2022 01 01; 275(1):45-53.
Score: 0.127
-
Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study). Clin Cancer Res. 2019 Sep 15; 25(18):5493-5502.
Score: 0.106
-
Pancreatic cancer disparities in African Americans. Pancreas. 2015 May; 44(4):522-7.
Score: 0.080